Tepotinib治疗<em> MET</em>14外显子跳读突变非小细胞肺癌患者的疗效与安全性

Tepotinib治疗 MET14外显子跳读突变非小细胞肺癌患者的疗效与安全性

评价者：邬麟¹, 文献合成者：卢红莲²

Efficacy and Safety of Tepotinib in Non-Small-Cell Lung Cancer With MET Exon 14 Skipping Mutations

Reviewer：WU Lin¹, Literature Co-worker：LU Hong-lian²